Revalid-Teva (Capsules) Instructions for Use
Marketing Authorization Holder
Teva Pharmaceutical Industries, Ltd. (Israel)
Manufactured By
Teva Pharmaceutical Works, Private Limited Company (Hungary)
ATC Code
A11AB (Multivitamins in combination with other drugs)
Dosage Form
| Revalid-Teva | Capsules: 30 pcs. |
Dosage Form, Packaging, and Composition
Capsules are hard gelatin, size No. 0, with a transparent dark green cap and a transparent light green body; the capsule contents are a powder from brownish-yellowish to yellowish-brown in color with lighter and darker inclusions, with a characteristic odor.
| 1 capsule | |
| Thiamine hydrochloride (vit. B1) | 1.5 mg |
| Calcium pantothenate (vit. B5) | 50 mg |
| Pyridoxine hydrochloride (vit. B6) | 10 mg |
| Para-aminobenzoic acid (vit. Bx) | 20 mg |
| Iron | 2 mg |
| Copper | 500 mcg |
| Zinc | 2 mg |
| Trace elements in chelate complex | 65 mg |
| L-Cystine | 50 mg |
| D,L-Methionine | 100 mg |
| Oat extract | 50 mg |
| Triticum vulgare germ extract | 50 mg |
| Medicinal yeast | 50 mg |
Excipients: colloidal silicon dioxide – 4.5 mg.
Capsule shell composition: gelatin – 98 mg, indigo carmine (E132) – 0.05 mg, quinoline yellow (E104) – 0.11 mg.
10 pcs. – blisters (3) – cardboard packs.
Clinical-Pharmacological Group
Vitamin complex with trace elements and components of natural origin, contributing to the improvement of hair structure
Pharmacotherapeutic Group
Multivitamin agent + other drugs
Pharmacological Action
The components of the drug contribute to the normalization of metabolic processes.
Pharmacokinetics
Pharmacokinetic data for the drug Revalid are not provided.
Indications
Diseases accompanied by impaired hair and nail structure and hair loss
- To improve the surface structure and appearance of hair and reduce its brittleness;
- To improve the trophism of hair follicles and nails;
- To increase resistance and slow down hair loss as a result of exposure to adverse environmental factors and undesirable effects (mechanical damage; exposure of a chemical nature – hair dyeing; exposure to X-rays and ultraviolet rays).
ICD codes
| ICD-10 code | Indication |
| E50-E64 | Other types of nutritional deficiencies (E50-E64) |
| L60.8 | Other diseases of nails |
| L65.9 | Noncicatricial alopecia, unspecified |
| L67 | Hair color and hair shaft abnormalities |
| ICD-11 code | Indication |
| 5B7Z | Malnutrition, unspecified |
| ED70.Y | Other specified alopecia or hair loss |
| ED73 | Acquired hair shaft disorders |
| EE13 | Certain disorders affecting nail or periungual tissues |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Adults — 1 capsule 3 times/day during meals or immediately before meals. The course of treatment is 2-3 months. Repeated courses are possible after a doctor’s recommendation.
In particularly severe cases (with intensive or diffuse hair loss), an intensive course of treatment is suggested: 2 capsules 3 times/day for the first month, and then you can switch to the usual course of treatment: 1 capsule 3 times/day as recommended by a doctor.
Adverse Reactions
Possible allergic reactions to the components of the drug.
From the digestive system, at a dosage of 6 capsules/day, minor digestive disorders may appear; in this case, the dose should be reduced to 3 capsules/day.
Contraindications
- For hair loss or damage to areas of the scalp caused by hormonal disorders;
- For inflammatory and fungal diseases of the nails;
- Increased sensitivity to the components of the drug.
Use in Pregnancy and Lactation
Data on the safety and efficacy of the drug during pregnancy and lactation (breastfeeding) are not provided.
Pediatric Use
The drug is prescribed for adults.
Drug Interactions
Reduces the intensity of the action of sulfonamides.
Storage Conditions
The drug should be stored out of the reach of children, in a dry place at a temperature from 15°C (59°F) to 25°C (77°F).
Shelf Life
The shelf life is 3 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer